David D. O'Toole, Chief Financial Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), bought 200 shares at $19.13 ($4K) on 2021-09-14, disclosed to the SEC on 2021-09-15.
Open-market purchase of $4k OPNT by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.05 | 21 | $400 | 10.5% |
| 2 | $19.13 | 179 | $3K | 89.5% |
| Total | $19.12 avg | 200 | $4K | 100% |
| Filing → |
| RCEL | BUY | 2026-03-11 | $9K | — | Filing → |
| RCEL | BUY | 2026-02-23 | $12K | — | Filing → |
| RCEL | BUY | 2025-08-26 | $9K | — | Filing → |